KV7.2 kanalaestruktura, erregulazioa eta kitzikagarritasun neuronalean duen ekintza

  1. Eider Nuñez 1
  2. Arantza Muguruza-Montero 1
  3. Ainhoa Rodriguez de Yurre 2
  4. Ariane Araujo 3
  5. Alvaro Villarroel 1
  6. Janire Urrutia 1
  1. 1 Instituto Biofisika (CSIC, UPV/EHU)
  2. 2 Fundació Privada per la recerca i la docencia Sant Joan de Déu
  3. 3 Universidad del País Vasco/Euskal Herriko Unibertsitatea
    info

    Universidad del País Vasco/Euskal Herriko Unibertsitatea

    Lejona, España

    ROR https://ror.org/000xsnr85

Journal:
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria

ISSN: 0214-9001

Year of publication: 2021

Issue: 39

Pages: 37-60

Type: Article

DOI: 10.1387/EKAIA.21870 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria

Abstract

Potassium channels are present in almost all cell membranes and perform important biological functions, including electrical currents control in excitable cells. The KV7 channels familiy consists of 5 members (KV7.1-KV7.5) and the genes that encode them are related to significant pathologies. The structure of KV7 channels shares the usual six transmem-brane segment structure, with intracellular N- and C-termini. In neurons, KV7.2 and KV7.3 are the main channels, which generate the M-current that controls neuronal excitability. The M-current regulation is complex as it can be regulated by different signalling pathways. It is regulated by Gq/11-coupled receptors, and the signaling pathway depends on the activated receptor. Thus, the M1 muscarinic acetylcholine receptor inhibits KV7.2 current by PIP2 depletion. While the bradykinin receptor inhibits it through the calcium concentration increase driven by IP3. Among these mechanisms several proteins are involved, such as calmodulin, protein kinases and anchor proteins. In this review we will focus on KV7.2 channel, as it is involved in several diseases and for its complex regulation it can be an interesting target from a pharmacological point of view.